Search Results - "Kupa, Leonard V.K."

ALTERAÇÃO DE CONDUTA CLÍNICA EM PACIENTES SÉPTICOS GRAVEMENTE ENFERMOS COM QUEIMADURAS PELO AJUSTE DA DOSE DA VANCOMICINA CONTRA CEPAS GRAM-POSITIVAS MIC 2 MG/L PELA ABORDAGEM FARMACOCINÉTICA-FARMACODINÂMICA by de Camargo, Thais Vieira, Kupa, Leonard V.K., Junior, João M. Silva, Junior, Elson M. Silva, Oliveira, Amanda M.R.R., Oliveira, Estela M., Gomides, Aline S., Ferreira, Gabriela A., Oliveira, Thiago C., Gomez, David S, Santos, Silvia R.C.J.

“…O regime de dose empírica de vancomicina recomendado geralmente não atinge o alvo terapêutico em pacientes sépticos em estado crítico da Unidade de Terapia…”
Get full text

SARS-CoV-2 vaccine in patients with systemic sclerosis: impact of disease subtype and therapy by Sampaio-Barros, Percival Degrava, Medeiros-Ribeiro, Ana Cristina, Luppino-Assad, Ana Paula, Miossi, Renata, da Silva, Henrique Carriço, Yuki, Emily F V N, Pasoto, Sandra G, Saad, Carla G S, Silva, Clóvis A, Kupa, Léonard V K, Deveza, Giordano B H, Pedrosa, Tatiana N, Aikawa, Nádia E, Bonfá, Eloisa

“…Abstract Objective To analyse the safety, immunogenicity and factors affecting antibody response to Severe Acute Respiratory Syndrome–Coronavirus–2…”
Get full text

Interaction of TNFi and conventional synthetic DMARD in SARS-CoV-2 vaccine response in axial spondyloarthritis and psoriatic arthritis by G.S. Saad, Carla, S.R. Silva, Matheus, Sampaio-Barros, Perceval D., C.B. Moraes, Julio, G. Schainberg, Cláudia, Gonçalves, Celio R., Shimabuco, Andrea Y., Aikawa, Nadia E., F.N. Yuki, Emily, G. Pasoto, Sandra, V.K. Kupa, Leonard, K. Aoyama, Renato, S.R. Araujo, Carlo, Silva, Clóvis A., Medeiros-Ribeiro, Ana C., Bonfa, Eloisa

“…•TNF inhibitors attenuate humoral response to SARS-CoV-2 vaccine in SpA patients.•Sulfasalazine has a positive impact on vaccine antibody production.•Vaccine…”
Get full text

Physical Activity: A Strategy to Improve Antibody Response to a SARS-CoV-2 Vaccine Booster Dose in Patients With Autoimmune Rheumatic Diseases by Gualano, Bruno, Sieczkowska, Sofia M, Lemes, Ítalo Ribeiro, da Silva, Rafael Pires, Pinto, Ana J, Mazzolani, Bruna C, Smaira, Fabiana I, Aikawa, Nadia E, Kupa, Leonard V K, Pasoto, Sandra G, Medeiros-Ribeiro, Ana C, Saad, Carla G S, Yuk, Emily F N, Silva, Clovis A, Swinton, Paul, Hallal, Pedro C, Roschel, Hamilton, Bonfa, Eloisa

“…Physical activity associates with improved immunogenicity following a 2-dose schedule of CoronaVac (Sinovac's inactivated SARS-CoV-2 vaccine) in patients with…”
Get more information

Anti-SARS-CoV-2 inactivated vaccine in patients with ANCA-associated vasculitis: Immunogenicity, safety, antibody decay and the booster dose by Pereira, Rosa M.R., Dagostin, Marilia A., Caparbo, Valeria F., Sales, Lucas P., Pasoto, Sandra G., Silva, Clovis A., Yuki, Emily F.N., Saad, Carla G.S., Medeiros-Ribeiro, Ana C., Kupa, Leonard V.K., Fusco, Solange R.G., Martins, Victor A.O., Martins, Carolina C.M.F., Barbas, Carmen Valente, Shinjo, Samuel K., Aikawa, Nadia E., Bonfa, Eloisa

“…•This study provides evidence that CoronaVac, an inactivated virus vaccine against SARS-CoV-2, is safe and has a moderate immunogenicity in AAV.•The authors…”
Get full text

UHPLC-MS/MS Method for Determination of Hydroxychloroquine and Its Main Metabolites in Oral Fluid and Whole Blood for Therapeutic Drug Monitoring by Duarte, Nilo J C, Kupa, Léonard V K, Ferreira-Filho, Julio C R, Fontoura, Nicole, Chalom, Marc Y, Romano, Paschoalina, Ebner, Pérsio A R, Silva, Clovis A A, Carvalho, Valdemir M, Bonfá, Eloisa

“…Hydroxychloroquine (HCQ) blood levels are used to monitor efficacy, safety, and patient adherence during treatment. Oral fluid has emerged as an alternative…”
Get full text

Primary dental care treatment in primary Sjögren's syndrome: a possible role in improving salivary flow rate by Martins, Victor A O, Floriano, Tamires F, Leon, Elaine P, Villamarín, Lorena E B, Deveza, Giordano B H, Aikawa, Nádia E, Silva, Clovis A A, Kupa, Léonard V K, Peres, Maria Paula S M, Braz-Silva, Paulo H, Bonfá, Eloisa, Pasoto, Sandra G

“…Primary Sjögren's syndrome (pSS) is an inflammatory chronic disorder that mainly affects exocrine glands. Additionally, oral infections can aggravate the…”
Get more information

Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2–3 mg/kg/day): 12-month prospective randomized controlled trial by Zanetti, Caio B., Pedrosa, Tatiana, Kupa, Léonard de V. K., Aikawa, Nadia E., Borba, Eduardo F., Vendramini, Margarete B. G., Silva, Clovis A., Pasoto, Sandra G., Bonfa, Eloisa

“…Introduction The American Academy of Ophthalmology (2016-AAO) recommended hydroxychloroquine (HCQ) dose not to exceed 5 mg/kg/day (real body weight). Recently,…”
Get full text